Presentations & Publications
2022
- Osteosynthesis-associated infection of the lower limbs by multi-drug and extensively drug-resistant Gram negative bacteria: A multi-centrecohort study (endorsed by ESGIAI-the ESCMID study group on implant-associated infections); Efthymia Giannitsiotiet al.; Journal of Bone and Joint Infections (J Bone Jt Infect) (1st Dec 2022)
- Microbiological Characterization of Cutibacteriumacnes Strains Isolated from Prosthetic Joint Infections. Salar-Vidal L et al.; Antibiotics (Basel). 2022 Sep 16;11(9):1260
- The State of Microbiology Diagnostic of Prosthetic Joint Infection in Europe: An In-Depth Survey Among Clinical Microbiologists. Erlangga Yussuf et al.; Front Microbiol. 2022 Jun 20;13:906989.
- Should all patients with a culture-negative periprosthetic joint infection be treated with antibiotics?: a multicentreobservational study. van Sloten M et al.; Bone Joint J. 2022 Jan;104-B(1):183-188.
2021
- The EBJIS definition of periprosthetic joint infection. Martin McNally, Ricardo Sousa, Marjan Wouthuyzen-Bakker et al. Bone Joint J. 2021 Jan;103-B(1):18-25. doi: 10.1302/0301-620X.103B1.BJJ-2020-1381.R1.
- Genomic Analysis of Cutibacterium acnes Strains Isolated from Prosthetic Joint Infections. Llanos Salar-Vidal, Yvonne Achermann , John-Jairo Aguilera-Correa et al. Microorganisms 2021 Jul 14;9(7):1500. doi: 10.3390/microorganisms9071500.
- The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus. Karel-Jan Dag François Lensen, Rosa Escudero-Sanchez, Javier Cobo et al. J Bone Jt Infect. 2021 Aug 17;6(7):313-319. doi: 10.5194/jbji-6-313-2021.
- How to handle concomitant asymptomatic prosthetic joints during an episode of hematogenous PJI, a multicentre analysis. Marjan Wouthuyzen-Bakker, Marine Sebillotte, Cédric Arvieux et al. Clinical infectious diseases 2021 Dec 6;73(11):e3820-e3824. doi: 10.1093/cid/ciaa1222.
- The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections. Yvonne Achermann, Katharina Kusejko, Álvaro Auñón et al. Clinical infectious diseases 2021 Jun 15;72(12):e1064-e1073. doi: 10.1093/cid/ciaa1839
- Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection. Marjan Wouthuyzen-Bakker, Jaime Lora-Tamayo, Alex Soriano, ESGIAI. Clinical Infectious Diseases Mar 3;70(6):1259-1260. doi: 10.1093/cid/ciz631.
2020
- Lower success rate of débridement and implant retention in late acute versus early acute periprosthetic joint infection caused by Staphylococcus spp. results from a matched cohort study.
Wouthuyzen-Bakker M, Sebillotte M, Huotari K, ESCMID Study Group for Implant-Associated Infections (ESGIAI), et al. Clin Orthop Relat Res 2020. doi: 10.1097/CORR.0000000000001171. - Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital.
Broly M, Ruffier d'Epenoux L, Guillouzouic A, et al. Eur J Clin Microbiol Infect Dis 2020; 39:1357-1364. doi: 10.1007/s10096-020-03852-5. - How to handle concomitant asymptomatic prosthetic joints during an episode of hematogenous PJI, a multicentre analysis.
Wouthuyzen-Bakker M, Sebillotte M, Arvieux C et al. Clin Infect Dis 2020; ciaa1222. doi: 10.1093/cid/ciaa1222. - The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections.
Achermann Y, Kusejko K, Auñón A et al. Clin Infect Dis 2020; ciaa1839. doi: 10.1093/cid/ciaa1839. - 2020 Frank Stinchfield Award: Identifying who will fail following irrigation and debridement for prosthetic joint infection.
Shohat N, Goswami K, Tan T L et al. Bone Joint J 2020; 102-B:11–19. doi:10.1302/0301-620x.102b7.bjj-2019-1628.r1.
2019
- Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study.
Escudero-Sanchez R, Senneville E, Digumber M, et al. Clin Microbiol Infect 2019. pii: S1198-743X(19)30492-6. doi: 10.1016/jcmi2019.09.007. - Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic
joint infections: Role of surgery and impact of colistin administration.
Papadopoulos A, Ribera A, Mavrogenis AF, et al. Int J Antimicrob Agents 2019;53:294-301. doi: 10.1016/j.ijantimicag.2018.10.018 - Corrigendum to "Multidrug-resistant and extensively drug-resistant Gram-negative
prosthetic joint infections: Role of surgery and impact of colistin administration"
Papadopoulos A, Ribera A, Mavrogenis AF, et al. Int J Antimicrob Agents 2019;S0924-8579(19)30058-5. doi: 10.1016/j.ijantimicag.2019.03.005. - Clinical outcome and risk factors for failure in late acute prosthetic joint
infections treated with debridement and implant retention.
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, et al. J Infect 2019;78:40-47. doi: 10.1016/j.jinf.2018.07.014. - Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study.
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, et al, J Infect 2019;79:199-205. doi: 10.1016/j.jinf.2019.07.003. - Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection.
Wouthuyzen-Bakker M, Lora-Tamayo J, Soriano A; ESCMID Study Group for Implant-associated Infections. Clin Infect Dis 2019 pii: ciz631. doi: 10.1093/cid/ciz631 - Debridement, antibiotics and implant retention is a viable treatment option for early periprosthetic joint infection presenting more than four weeks after index arthroplasty.
Löwik CAM, Parvizi J, Jutte PC et al. Clin Infect Dis 2019. pii: ciz867. doi: 10.1093/cid/ciz867.